Last $7.01 USD
Change Today -0.38 / -5.14%
Volume 66.4K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 4:30 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitleKey Developments
Stelios Papadopoulos Ph.D. 100 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Bruce Carter Ph.D. 212 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Mark Foletta CPA 51 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 
B. Parshall Esq., J.D. 47 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitle
David Baltimore Ph.D. 120 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Bruce Carter Ph.D. 212 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
William Rastetter Ph.D. 103 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
RGLS Compensation vs. Industry
600.0K
367.2K
Chief Executive Officer
Share price activity for REGULUS THERAPEUTICS INC (RGLS)
52 Week Price Performance
RGLS
Industry Average

Nominating Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitleKey Developments
Stelios Papadopoulos Ph.D. 100 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeRegulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
06/16/14
David Baltimore Ph.D. 120 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeRegulus Appoints Martin Beaulieu as Head of Regulus Micromarkers R&D Division
02/13/14
Mark Foletta CPA 51 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeRegulus Therapeutics Inc. Announces Addition of David Szekeres to its Executive Management Team as Chief Business Officer and General Counsel
02/4/14
William Rastetter Ph.D. 103 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeRegulus Therapeutics Inc. Elects Bruce L.A. Carter, Mark G. Foletta, William Rastetter and Douglas Williams as Directors
06/12/13

Corporate Governance Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitle
David Baltimore Ph.D. 120 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Mark Foletta CPA 51 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Stelios Papadopoulos Ph.D. 100 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
William Rastetter Ph.D. 103 Relationships--
RGLS and Competitor
Insiders vs. External
Board
8%
92%
Regulus Therapeutics Inc.
31%
69%
Silence Therapeutics plc
0%
100%
Enzon Pharmaceuticals Inc.
20%
80%
Benitec Biopharma Limited
8%
92%
Prosensa Holding N.V.
8%
92%
Galena Biopharma, Inc.
Insiders
External Board Members

Advisory Committee* - regulus therapeutics inc (RGLS)

Name (Board Relationships)/Title Board Affiliations
David Baltimore 120 Relationships
Chairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
No other board affiliations
David Bartel 28 Relationships
Member of Scientific Advisory Board
No other board affiliations
Gregory Hannon 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Markus Stoffel 26 Relationships
Member of The Scientific Advisory Board
No other board affiliations
Thomas Tuschl 25 Relationships
Member of The Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $7.01 USD -0.38

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$1.08 AUD -0.055
Enzon Pharmaceuticals Inc $1.25 USD -0.01
Galena Biopharma Inc $2.32 USD -0.01
Prosensa Holding NV $9.40 USD -0.43
Silence Therapeutics PLC 208.50 GBp -2.50
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.0x
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.